ICRA has assigned its long term rating of [ICRA]BB+ (pronounced ICRA double B plus) to the Rs. 19.90
crore bank facilities of Uni Medicolabs (UML) The outlook on the long-term rating is ‘Stable’.
The assigned rating takes into account the long experience of the promoters in the pharmaceutical
business being API distributors and suppliers and established relations with key pharmaceutical
companies in domestic market. As a pharmaceutical contract manufacturer, UML started operations in
2009 initially operating as a loan licensee and having shifted to Principal to Principal model (P2P)
supplies in 2013-14. Although the firm has been able to ramp up its capacity utilization for the capsules
and injectables facility, its utilization for the tablets and dry syrups remains moderate. The available
capacity as well as new orders from customers is expected to drive sales growth of the firm in the near
term.
Vacancy Details
Officer / Executive – Analytical QA
- Experience : 3 to 6 Years
- Education : MSc / B Pharmacy / M Pharma
- Role : Analytical Data Review
Officer / Executive – Qualification
- ROLE : Qualification & Validation
- Education : B pharmacy & M pharmacy
Stability Officer
- Minimum Qualification : B Pharmacy / M Pharma
- Experience : 02 to 04 years
- Role : Stability Study
Officer / Executive Documentation
- Experience : 01 to 05 years
- ROLE : Documents Preparation & Management
Officer – IPQA
- Role : IPQA
Date: 13-02-2022
Venue : UNI MEDICOLABS, DEHRADUN, Plot No. 21-22, Pharmacity Selaqui Dehradun-248011, Uttarakhand, India
Contact to HR: +91-9258022611/+91-9068557631
